These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 32859232)

  • 1. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.
    Qin X; Zhang J; Lin Y; Sun XM; Zhang JN; Cheng ZQ
    J Transl Med; 2020 Aug; 18(1):326. PubMed ID: 32859232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
    Yan TH; Qiu C; Sun J; Li WH
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.
    Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
    Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
    Su Y; Xie R; Xu Q
    Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 10. miR-215-5p Plays a Key Role in Suppressing Vascular Invasion and Recurrence in Hepatocellular Carcinoma by Blocking Vasculogenic Mimicry.
    Zhang H; Lan X; Cai L; Gao X; Gao F; Yu D; Zhang J; Zhang J; Tai Q
    Front Biosci (Elite Ed); 2024 Feb; 16(1):6. PubMed ID: 38538524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.
    Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q
    Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
    Li W; Jiang Y; Pan Q; Yang G
    Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
    Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
    J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
    Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
    Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF8-miR-552-5p Axis Modulates ACSL4-Mediated Ferroptosis in Hepatocellular Carcinoma.
    Yang H; Sun W; Bi T; Sun J; Lu Z; Li J; Wei H
    DNA Cell Biol; 2023 Jun; 42(6):336-347. PubMed ID: 37126948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.